PLCB3 and inflammatory bowel disease: As PLC-β3 is the only one among four isozymes (PLC-β1~β4) that is highly expressed in IECs (Figure S1A–C), we studied a potential role of PLC-β3 in IBD pathogenesis, using a dextran sodium sulfate (DSS)-induced colitis model [17].